During the previous funding period, we uncovered a positive feedback cycle that favors aberrant overexpression of STAR, P450arom and COX-2 in the pathologic endometriosis tissue. StAR-P450arom pathway-derived estradiol stimulates COX-2 expression, whereas COX-2-derived PGE2 induces StAR and P450arom expression via cAMP. The clinical relevance was exemplified by the recent and successful use of aromatase inhibitors to treat endometriosis. We generated the following preliminary data: (i) StAR and P450arom are the key steroidogenic genes that mediate PGE2-dependent estradiol formation in endometriosis-derived stromal cells. (ii) Multiple fail-safe mechanisms including inhibitory transcription factors (e.g., COUP-TF) and corepressors (e.g., WT-1) in normal endometrial stromal cells render these cells nonresponsive to PGE2 or cAMP analogs and silence StAR and P450arom promoters. (iii) In endometriotic stromal cells, the aberrantly expressed transcriptional enhancer SF-1 mediates PGE2- dependent induction of multiple steroidogenic promoters (e.g., StAR and P450arom), whereas transcriptional repressors are downregulated. (iv) IL-1beta, PGE2 itself, estradiol and VEGF stimulate COX-2 in endometriotic stromal and uterine endothelial cells. We hypothesize that PGE2 induces (via cAMP) binding of homologous enhancer-type multimeric transcriptional complexes that share common factors to key steroidogenic promoters in endometriotic stromal cells. The key mechanism for steroidogenesis in endometriosis is the aberrant presence of SF-1 that is the critical factor for assembling these stimulatory complexes. We propose the following aims: 1- To determine in vivo distribution of StAR and estradiol levels in endometriosis tissues and characterize PGE2-mediated STAR, protein and mRNA levels in endometriotic stromal cells. 2 - To identify common cis-acting elements, transcriptional factors and co-regulators responsible for PGE2- mediated co-activation of StAR and P450arom promoters in endometriotic cells. 3 - To define in situ composition of multimeric complexes responsible for PGE2-dependent co-activation of key steroidogenic promoters in endometriotic cells. 4 - To determine the molecular mechanisms responsible for SF-1 expression in endometriotic stromal cells. Investigation of local feedback mechanisms responsible for interactions between estrogen biosynthesis, tissue growth, and inflammation will lead to the rational design of novel drug treatments.
Brooks, D C; Zhao, H; Yilmaz, M B et al. (2012) Glucocorticoid-induction of hypothalamic aromatase via its brain-specific promoter. Mol Cell Endocrinol 362:85-90 |
Pavone, Mary Ellen; Bulun, Serdar E (2012) Aromatase inhibitors for the treatment of endometriosis. Fertil Steril 98:1370-9 |
Dyson, Matthew T; Bulun, Serdar E (2012) Cutting SRC-1 down to size in endometriosis. Nat Med 18:1016-8 |
Yilmaz, M Bertan; Wolfe, Andrew; Zhao, Hong et al. (2011) Aromatase promoter I.f is regulated by progesterone receptor in mouse hypothalamic neuronal cell lines. J Mol Endocrinol 47:69-80 |
Bulun, Serdar E; Cheng, You-Hong; Pavone, Mary Ellen et al. (2010) 17Beta-hydroxysteroid dehydrogenase-2 deficiency and progesterone resistance in endometriosis. Semin Reprod Med 28:44-50 |
Trukhacheva, Elena; Lin, Zhihong; Reierstad, Scott et al. (2009) Estrogen receptor (ER) beta regulates ERalpha expression in stromal cells derived from ovarian endometriosis. J Clin Endocrinol Metab 94:615-22 |
Bulun, Serdar E (2009) Endometriosis. N Engl J Med 360:268-79 |
Attar, Erkut; Tokunaga, Hideki; Imir, Gonca et al. (2009) Prostaglandin E2 via steroidogenic factor-1 coordinately regulates transcription of steroidogenic genes necessary for estrogen synthesis in endometriosis. J Clin Endocrinol Metab 94:623-31 |
Bulun, Serdar E; Simpson, Evan R (2008) Aromatase expression in women's cancers. Adv Exp Med Biol 630:112-32 |
Bulun, Serdar E; Chen, Dong; Lu, Meiling et al. (2007) Aromatase excess in cancers of breast, endometrium and ovary. J Steroid Biochem Mol Biol 106:81-96 |
Showing the most recent 10 out of 35 publications